Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
Must Read: Experts in cell line development offer new insights into using transposase-mediated semi-targeted integrations and AI to identify robust and stable pools that can help you to meet IND and GMP milestones fast and effectively. | Explore the latest advances in transposase CLD, helping biopharma teams improve productivity, stability, and speed to the clinic.
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise

Explore how continuous manufacturing strategies can support more scalable, efficient, and cost-effective mAb production. Download…

Strengthening core CDO values for cell line development | Strengthening core CDO values for cell line development

Targeted protein degradation is changing how drug discovery teams think about disease biology. For many years, small molecule…

Modern drug development demands faster, more scalable gene expression insights. Download this white paper to explore how…

After speedrunning a series of major manufacturing milestones in the past year and a half, the “biotech floodgates” have opened…

Contract manufacturing powerhouse Lonza is growing in more ways than one. | Contract manufacturing powerhouse Lonza is growing in…